{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:41:21Z","timestamp":1783395681652,"version":"3.54.6"},"reference-count":169,"publisher":"Oxford University Press (OUP)","issue":"32","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Many previously unexplained life-threatening ventricular arrhythmias and sudden cardiac deaths (SCDs) in young individuals are now recognized to be genetic in nature and are ascribed to a growing number of distinct inherited arrhythmogenic diseases. These include hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia (VT), and short QT syndrome. Because of their lower frequency compared to coronary disease, risk factors for SCD are not very precise in patients with inherited arrhythmogenic diseases. As randomized studies are generally non-feasible and may even be ethically unjustifiable, especially in the presence of effective therapies, the risk assessment of malignant arrhythmic events such as SCD, cardiac arrest due to ventricular fibrillation (VF), appropriate implantable cardioverter defibrillator (ICD) interventions, or ICD therapy on fast VT\/VF to guide ICD implantation is based on observational data and expert consensus. In this document, we review risk factors for SCD and indications for ICD implantation and additional therapies. What emerges is that, allowing for some important differences between cardiomyopathies and channelopathies, there is a growing and disquieting trend to create, and then use, semi-automated systems (risk scores, risk calculators, and, to some extent, even guidelines) which then dictate therapeutic choices. Their common denominator is a tendency to favour ICD implantation, sometime with reason, sometime without it. This contrasts with the time-honoured approach of selecting, among the available therapies, the best option (ICDs included) based on the clinical judgement for the specific patient and after having assessed the protection provided by optimal medical treatment.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehac298","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T03:10:40Z","timestamp":1655781040000},"page":"3029-3040","source":"Crossref","is-referenced-by-count":39,"title":["Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1487-0392","authenticated-orcid":false,"given":"Domenico","family":"Corrado","sequence":"first","affiliation":[{"name":"Inherited Arrhythmogenic Cardiomyopathies and Sports Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova Medical School , Padova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5277-9296","authenticated-orcid":false,"given":"Mark S","family":"Link","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Texas Southwestern Medical Center , Dallas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0367-1048","authenticated-orcid":false,"given":"Peter J","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"2022082023573298800_ehac298-B1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-020-0188-7","article-title":"Inherited cardiac arrhythmias","volume":"6","author":"Schwartz","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"2022082023573298800_ehac298-B2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"2022082023573298800_ehac298-B4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","article-title":"Arrhythmogenic cardiomyopathy","volume":"121","author":"Corrado","year":"2017","journal-title":"Circ Res"},{"key":"2022082023573298800_ehac298-B6","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1093\/eurheartj\/eht089","article-title":"The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy","volume":"34","author":"Schwartz","year":"2013","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol"},{"key":"2022082023573298800_ehac298-B8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198801213180301","article-title":"Right ventricular cardiomyopathy and sudden death in young people","volume":"318","author":"Thiene","year":"1988","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B10","doi-asserted-by":"crossref","first-page":"e003631","DOI":"10.1161\/CIRCEP.115.003631","article-title":"Relationship between arrhythmogenic right ventricular cardiomyopathy and Brugada syndrome: new insights from molecular biology and clinical implications","volume":"9","author":"Corrado","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"2022082023573298800_ehac298-B13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2022082023573298800_ehac298-B14","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCULATIONAHA.109.913871","article-title":"Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia","volume":"122","author":"Corrado","year":"2010","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2014.04.035","article-title":"Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment","volume":"64","author":"Link","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jacc.2014.12.031","article-title":"Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience","volume":"65","author":"Conte","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B18","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.110.950147","article-title":"Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT syndrome implantable cardioverter-defibrillator (LQTS ICD) registry","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCEP.112.975268","article-title":"The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention","volume":"6","author":"Olde Nordkamp","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2459\/JCM.0000000000000395","article-title":"Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience","volume":"17","author":"Migliore","year":"2016","journal-title":"J Cardiovasc Med"},{"key":"2022082023573298800_ehac298-B21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.hrthm.2015.09.020","article-title":"When the risk is sudden death, does quality of life matter?","volume":"13","author":"Schwartz","year":"2016","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B22","first-page":"e533","article-title":"AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: Executive summary: A report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"2020","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B24","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jacep.2017.08.017","article-title":"Long-term experience with the subcutaneous implantable cardioverter-defibrillator in teenagers and young adults","volume":"3","author":"Bettin","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2022082023573298800_ehac298-B25","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2016.08.044","article-title":"Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy","volume":"68","author":"Brouwer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B26","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC). Endorsed by: Association for European paediatric and congenital cardiology (AEPC)","volume":"2015","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B27","first-page":"2733","article-title":"ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"2014","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B28","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B29","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/europace\/euab238","article-title":"Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)","volume":"24","author":"Mazzanti","year":"2022","journal-title":"Europace"},{"key":"2022082023573298800_ehac298-B31","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2004.12.067","article-title":"The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms","volume":"45","author":"Autore","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B35","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B36","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.amjcard.2010.06.077","article-title":"Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy","volume":"106","author":"Bos","year":"2010","journal-title":"Am J Cardiol"},{"key":"2022082023573298800_ehac298-B37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management","volume":"69","author":"Rowin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B38","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1136\/heartjnl-2013-305471","article-title":"Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy","volume":"100","author":"Ismail","year":"2014","journal-title":"Heart"},{"key":"2022082023573298800_ehac298-B39","doi-asserted-by":"crossref","first-page":"e004604","DOI":"10.1161\/CIRCEP.116.004604","article-title":"Prognostic implications of nonsustained ventricular tachycardia in high-risk patients with hypertrophic cardiomyopathy","volume":"10","author":"Wang","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B40","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jacc.2020.04.045","article-title":"Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction","volume":"75","author":"Rowin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ahj.2013.06.009","article-title":"Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications","volume":"166","author":"Vriesendorp","year":"2013","journal-title":"Am Heart J"},{"key":"2022082023573298800_ehac298-B42","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B43","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.hrthm.2019.04.040","article-title":"Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: an international multicenter study","volume":"16","author":"Balaji","year":"2019","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amjcard.2020.04.042","article-title":"Prediction and prevention of sudden death in young patients (&lt; 20 years) with hypertrophic cardiomyopathy","volume":"128","author":"Rowin","year":"2020","journal-title":"Am J Cardiol"},{"key":"2022082023573298800_ehac298-B45","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/CIRCULATIONAHA.117.030792","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"136","author":"Calkins","year":"2017","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B46","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/01.CIR.0000143375.93288.82","article-title":"Natural history and risk stratification of arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"110","author":"Hulot","year":"2004","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B47","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jacc.2011.06.043","article-title":"Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention","volume":"58","author":"Bhonsale","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B48","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.CIR.0000121738.88273.43","article-title":"Implantable cardioverter\/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients","volume":"109","author":"Wichter","year":"2004","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B49","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/eurheartj\/ehr040","article-title":"Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry","volume":"32","author":"Pinamonti","year":"2011","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"2022082023573298800_ehac298-B51","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCEP.113.000233","article-title":"Risk stratification in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"6","author":"Bhonsale","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCIMAGING.113.000210","article-title":"Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"7","author":"Saguner","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022082023573298800_ehac298-B53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCEP.111.974881","article-title":"Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"6","author":"Migliore","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0004.2012.01919.x","article-title":"The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a:S358L. mutation in TMEM43","volume":"83","author":"Hodgkinson","year":"2013","journal-title":"Clin Genet"},{"key":"2022082023573298800_ehac298-B55","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/cvr\/cvx150","article-title":"Arrhythmogenic cardiomyopathy: pathology, genetics, and concepts in pathogenesis","volume":"113","author":"Hoorntje","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2022082023573298800_ehac298-B56","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1093\/eurheartj\/ehy567","article-title":"An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis","volume":"39","author":"Chatterjee","year":"2018","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B57","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/eurheartj\/ehx011","article-title":"Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome","volume":"38","author":"Akdis","year":"2017","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B58","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehab355","article-title":"Arrhythmic risk stratification in arrhythmogenic cardiomyopathy: new predictors for left-sided variants?","volume":"42","author":"Corrado","year":"2021","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B59","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p. Ar:g14d. el mutation carriers-reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B60","doi-asserted-by":"crossref","first-page":"e008509","DOI":"10.1161\/CIRCEP.120.008509","article-title":"Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration","volume":"14","author":"Cadrin-Tourigny","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B61","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/CIRCULATIONAHA.117.030437","article-title":"International external validation study of the 2014 European society of cardiology guidelines on sudden cardiac death prevention in hypertrophic cardiomyopathy (EVIDENCE-HCM)","volume":"137","author":"O\u2019Mahony","year":"2018","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B62","first-page":"1111","volume-title":"Cardiac electrophysiology: from cell to bedside","author":"Schwartz","year":"2022","edition":"8th ed"},{"key":"2022082023573298800_ehac298-B63","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-8703(75)90089-7","article-title":"The long Q-T syndrome","volume":"89","author":"Schwartz","year":"1975","journal-title":"Am Heart J"},{"key":"2022082023573298800_ehac298-B64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.71.1.17","article-title":"The long QT syndrome: a prospective international study","volume":"71","author":"Moss","year":"1985","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B65","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.84.3.1136","article-title":"The long QT syndrome. Prospective longitudinal study of;328, families","volume":"84","author":"Moss","year":"1991","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B66","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJM199810013391404","article-title":"Influence of the genotype on the clinical course of the long-QT syndrome. International long-QT syndrome registry research group","volume":"339","author":"Zareba","year":"1998","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B67","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","article-title":"Risk stratification in the long-QT syndrome","volume":"348","author":"Priori","year":"2003","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.hrthm.2008.10.017","article-title":"All LQT3 patients need an ICD: true or false?","volume":"6","author":"Schwartz","year":"2009","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B70","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2009.05.029","article-title":"Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy","volume":"54","author":"Spazzolini","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B71","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1046\/j.1540-8167.2003.03339.x","article-title":"How really rare are rare diseases? The intriguing case of independent compound mutations in the long QT syndrome","volume":"14","author":"Schwartz","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022082023573298800_ehac298-B72","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.CIR.0000125524.34234.13","article-title":"Compound mutations: a common cause of severe long-QT syndrome","volume":"109","author":"Westenskow","year":"2004","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B73","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/hc0702.105124","article-title":"Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel","volume":"105","author":"Moss","year":"2002","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B74","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1093\/eurheartj\/ehab582","article-title":"Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region","volume":"42","author":"Schwartz","year":"2021","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B75","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/CIRCULATIONAHA.112.001216","article-title":"Calmodulin mutations associated with recurrent cardiac arrest in infants","volume":"127","author":"Crotti","year":"2013","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B76","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/eurheartj\/ehz311","article-title":"Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the international calmodulinopathy registry","volume":"40","author":"Crotti","year":"2019","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B77","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/CIRCULATIONAHA.105.592899","article-title":"The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome","volume":"113","author":"Schwartz","year":"2006","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"2022082023573298800_ehac298-B79","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2006.08.057","article-title":"Long QT syndrome in adults","volume":"49","author":"Sauer","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B80","first-page":"3925","article-title":"Modifier genes for sudden cardiac death","volume":"39","author":"Schwartz","year":"2018","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B81","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/CIRCULATIONAHA.105.549071","article-title":"KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome","volume":"112","author":"Crotti","year":"2005","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B82","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.109.879643","article-title":"NOS1AP is a genetic modifier of the long-QT syndrome","volume":"120","author":"Crotti","year":"2009","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B83","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/CIRCGENETICS.113.000580","article-title":"AKAP9 is a genetic modifier of congenital long-QT syndrome type 1","volume":"7","author":"de Villiers","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"2022082023573298800_ehac298-B84","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCGENETICS.113.000023","article-title":"Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome","volume":"6","author":"Duchatelet","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"2022082023573298800_ehac298-B85","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cvr\/cvaa019","article-title":"MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes","volume":"117","author":"Lee","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2022082023573298800_ehac298-B86","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2018.01.078","article-title":"Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome","volume":"71","author":"Mazzanti","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B87","first-page":"e190","article-title":"AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart rhythm society","volume":"2018","author":"Al-Khatib","year":"2017","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B88","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.hrthm.2021.07.038","article-title":"PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients","volume":"2021","author":"Shah","year":"2021","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B89","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.jacc.2021.09.017","article-title":"Effectiveness of implantable cardioverter-defibrillators to reduce mortality in patients with long QT Syndrome","volume":"78","author":"Wang","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B90","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacep.2021.09.002","article-title":"Left cardiac sympathetic denervation for long QT syndrome","volume":"8","author":"Dusi","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2022082023573298800_ehac298-B91","doi-asserted-by":"crossref","first-page":"e008830","DOI":"10.1161\/CIRCEP.120.008830","article-title":"Left cardiac sympathetic denervation monotherapy in patients with congenital long QT syndrome","volume":"13","author":"Niaz","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B92","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review","volume":"15","author":"Roston","year":"2018","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B93","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B94","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/europace\/eus031","article-title":"The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands","volume":"14","author":"Hayashi","year":"2012","journal-title":"Europace"},{"key":"2022082023573298800_ehac298-B95","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2011.03.038","article-title":"Long-term follow-up of patients with short QT syndrome","volume":"58","author":"Giustetto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B96","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","article-title":"Novel insight into the natural history of short QT syndrome","volume":"63","author":"Mazzanti","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B97","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jacc.2012.12.025","article-title":"Long-term follow-up of a pediatric cohort with short QT syndrome","volume":"61","author":"Villafa\u00f1e","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B98","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS. EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B99","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/CIRCULATIONAHA.117.027983","article-title":"Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome: a Japanese multicenter registry","volume":"135","author":"Yamagata","year":"2017","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B100","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/heartjnl-2020-318258","article-title":"Brugada syndrome: update and future perspectives","volume":"108","author":"Marsman","year":"2022","journal-title":"Heart"},{"key":"2022082023573298800_ehac298-B101","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/01.CIR.0000104568.13957.4F","article-title":"Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest","volume":"108","author":"Brugada","year":"2003","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B102","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCEP.114.002647","article-title":"Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience","volume":"8","author":"Sieira","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B103","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada syndrome registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry","volume":"59","author":"Priori","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B105","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.115.017885","article-title":"Programmed ventricular stimulation for risk stratification in the Brugada Syndrome: a pooled analysis","volume":"133","author":"Sroubek","year":"2016","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B106","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/eurheartj\/ehaa763","article-title":"Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome","volume":"42","author":"Probst","year":"2021","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B107","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehx119","article-title":"A score model to predict risk of events in patients with Brugada syndrome","volume":"38","author":"Sieira","year":"2017","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B108","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/j.hrthm.2016.05.024","article-title":"J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"13","author":"Antzelevitch","year":"2016","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B109","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/eurheartj\/ehaa1100","article-title":"Risk stratification in Brugada syndrome: the challenge of the grey zone","volume":"42","author":"Delise","year":"2021","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B110","doi-asserted-by":"crossref","first-page":"e001748","DOI":"10.1136\/openhrt-2021-001748","article-title":"Implantable loop recorders in patients with heart disease: comparison between patients with and without syncope","volume":"8","author":"Assaf","year":"2021","journal-title":"Open Heart"},{"key":"2022082023573298800_ehac298-B111","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1093\/eurheartj\/ehab598","article-title":"Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy","volume":"42","author":"Nauffal","year":"2021","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"Validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B113","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/eurjpc\/zwab181","article-title":"External validation of the HCM risk-kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy","volume":"29","author":"Norrish","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2022082023573298800_ehac298-B114","doi-asserted-by":"crossref","first-page":"e005593","DOI":"10.1161\/CIRCEP.117.005593","article-title":"Performance of the 2015 international task force consensus statement risk stratification algorithm for implantable cardioverter-defibrillator placement in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"11","author":"Orgeron","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/europace\/euab162","article-title":"Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy","volume":"24","author":"Bosman","year":"2022","journal-title":"Europace"},{"key":"2022082023573298800_ehac298-B116","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.hrthm.2006.08.018","article-title":"Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia","volume":"3","author":"Mohamed","year":"2006","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B117","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1540-8167.2008.01211.x","article-title":"Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation","volume":"19","author":"Pizzale","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022082023573298800_ehac298-B118","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.0000143159.30585.90","article-title":"Efficacy of quinidine in high-risk patients with Brugada syndrome","volume":"110","author":"Belhassen","year":"2004","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B119","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.CIR.84.2.503","article-title":"Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report","volume":"84","author":"Schwartz","year":"1991","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B120","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.0000125523.14403.1E","article-title":"Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome","volume":"109","author":"Schwartz","year":"2004","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B121","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac134","article-title":"Cardiac sympathetic denervation in the prevention of genetically-mediated life-threatening ventricular arrhythmias","volume":"43","author":"Schwartz","year":"2022","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B122","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B123","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B124","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.hrthm.2015.09.001","article-title":"Quality of life after videoscopic left cardiac sympathetic denervation in patients with potentially life-threatening cardiac channelopathies\/cardiomyopathies","volume":"13","author":"Antiel","year":"2016","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B125","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B126","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/europace\/euv299","article-title":"The learning curve associated with the introduction of the subcutaneous implantable defibrillator","volume":"18","author":"Knops","year":"2016","journal-title":"Europace"},{"key":"2022082023573298800_ehac298-B127","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","article-title":"Randomized trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Dybro","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B128","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000484628","article-title":"Long-term prognosis after myectomy in hypertrophic obstructive cardiomyopathy with severe left ventricular hypertrophy","volume":"139","author":"An","year":"2018","journal-title":"Cardiology"},{"key":"2022082023573298800_ehac298-B130","doi-asserted-by":"crossref","first-page":"e007673","DOI":"10.1161\/CIRCINTERVENTIONS.118.007673","article-title":"Guideline-based referral for septal reduction therapy in obstructive hypertrophic cardiomyopathy is associated with excellent clinical outcomes","volume":"12","author":"Kimmelstiel","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"2022082023573298800_ehac298-B131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"ESC Scientific Document Group 2020. ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B132","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B133","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ejhf.181","article-title":"Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members","volume":"16","author":"Saberniak","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2022082023573298800_ehac298-B134","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","article-title":"Multidisciplinary study of right ventricular dysplasia investigators. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry","volume":"54","author":"Marcus","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B135","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B136","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10840-016-0209-3","article-title":"Should all patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy undergo epicardial catheter ablation?","volume":"48","author":"M\u00fcssigbrodt","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"key":"2022082023573298800_ehac298-B137","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euw332","article-title":"Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry","volume":"20","author":"Souissi","year":"2018","journal-title":"Europace"},{"key":"2022082023573298800_ehac298-B138","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/eurheartj\/ehab007","article-title":"Precision medicine and cardiac channelopathies: when dreams meet reality","volume":"42","author":"Gnecchi","year":"2021","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B139","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/eurheartj\/ehaa769","article-title":"1970\u20132020: 50 years of research on the long QT syndrome-from almost zero knowledge to precision medicine","volume":"42","author":"Schwartz","year":"2021","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/oxfordjournals.eurheartj.a061517","article-title":"The idiopathic long QT syndrome: the need for a prospective registry","volume":"4","author":"Schwartz","year":"1983","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B141","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/01.CIR.0000157069.91834.DA","article-title":"25th anniversary of the international Long-QT syndrome registry: an ongoing quest to uncover the secrets of long-QT syndrome","volume":"111","author":"Moss","year":"2005","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B142","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2012.07.046","article-title":"Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol","volume":"60","author":"Chockalingam","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B143","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1161\/01.CIR.92.12.3381","article-title":"Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy","volume":"92","author":"Schwartz","year":"1995","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B144","doi-asserted-by":"crossref","first-page":"e007280","DOI":"10.1161\/CIRCEP.118.007280","article-title":"Mexiletine shortens the QT Interval in patients with potassium channel-mediated type 2 long QT syndrome","volume":"12","author":"Bos","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B145","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJM197110142851607","article-title":"Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome","volume":"285","author":"Moss","year":"1971","journal-title":"N Engl J Med"},{"key":"2022082023573298800_ehac298-B146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0002-8703(75)90008-3","article-title":"Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome","volume":"89","author":"Schwartz","year":"1975","journal-title":"Am Heart J"},{"key":"2022082023573298800_ehac298-B147","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.hrthm.2009.03.024","article-title":"Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery","volume":"6","author":"Collura","year":"2009","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B148","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.hrthm.2009.04.009","article-title":"Cutting nerves and saving lives","volume":"6","author":"Schwartz","year":"2009","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B149","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.hrthm.2010.03.046","article-title":"Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy","volume":"7","author":"Odero","year":"2010","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B150","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B151","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCEP.112.971754","article-title":"Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation\/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome","volume":"5","author":"Coleman","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B152","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/eurheartj\/ehz309","article-title":"Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest","volume":"40","author":"van der Werf","year":"2019","journal-title":"Eur Heart J"},{"key":"2022082023573298800_ehac298-B153","doi-asserted-by":"crossref","first-page":"e004185","DOI":"10.1161\/CIRCEP.116.004185","article-title":"Management of Brugada syndrome 2016: should all high risk patients receive an ICD? Alternatives to implantable cardiac defibrillator therapy for Brugada syndrome","volume":"9","author":"Belhassen","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B154","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B155","doi-asserted-by":"crossref","first-page":"e005053","DOI":"10.1161\/CIRCEP.117.005053","article-title":"Electrical substrate elimination in 135 consecutive patients with Brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B156","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.117.032624","article-title":"Radiofrequency ablation of asymptomatic Brugada syndrome: don\u2019t go burning my heart","volume":"137","author":"Viskin","year":"2018","journal-title":"Circulation"},{"key":"2022082023573298800_ehac298-B157","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrcardio.2014.19","article-title":"Cardiac sympathetic denervation to prevent life-threatening arrhythmias","volume":"11","author":"Schwartz","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2022082023573298800_ehac298-B158","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/0002-9149(76)90420-3","article-title":"Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold","volume":"37","author":"Schwartz","year":"1976","journal-title":"Am J Cardiol"},{"key":"2022082023573298800_ehac298-B159","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/01.RES.40.6.536","article-title":"Effect of stellectomy and vagotomy on ventricular refractoriness in dogs","volume":"40","author":"Schwartz","year":"1977","journal-title":"Circ Res"},{"key":"2022082023573298800_ehac298-B160","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.RES.44.5.637","article-title":"Effects of unilateral stellectomy upon cardiac performance during exercise in dogs","volume":"44","author":"Schwartz","year":"1979","journal-title":"Circ Res"},{"key":"2022082023573298800_ehac298-B161","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.RES.41.1.51","article-title":"Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs","volume":"41","author":"Schwartz","year":"1977","journal-title":"Circ Res"},{"key":"2022082023573298800_ehac298-B162","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0002-9149(82)90043-1","article-title":"Left stellectomy and denervation supersensitivity in conscious dogs","volume":"49","author":"Schwartz","year":"1982","journal-title":"Am J Cardiol"},{"key":"2022082023573298800_ehac298-B163","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1113\/JP271870","article-title":"Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics","volume":"594","author":"Shivkumar","year":"2016","journal-title":"J Physiol"},{"key":"2022082023573298800_ehac298-B164","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.jacc.2017.04.035","article-title":"Cardiac sympathetic denervation for refractory ventricular arrhythmias","volume":"69","author":"Vaseghi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022082023573298800_ehac298-B165","doi-asserted-by":"crossref","first-page":"e003713","DOI":"10.1161\/CIRCEP.115.003713","article-title":"Role of bilateral sympathectomy in the treatment of refractory ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"9","author":"Riele AS","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022082023573298800_ehac298-B166","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.hrthm.2019.01.019","article-title":"Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy","volume":"16","author":"Assis","year":"2019","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B167","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.hrthm.2010.04.038","article-title":"Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications","volume":"7","author":"Schwartz","year":"2010","journal-title":"Heart Rhythm"},{"key":"2022082023573298800_ehac298-B168","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/2047487318805584","article-title":"Sport activity in patients with implantable defibrillator: Playing with death?","volume":"26","author":"Corrado","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2022082023573298800_ehac298-B169","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.112.000447","article-title":"Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry","volume":"127","author":"Lampert","year":"2013","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/32\/3029\/45477878\/ehac298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/32\/3029\/45477878\/ehac298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T00:00:23Z","timestamp":1661040023000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/32\/3029\/6611934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":169,"journal-issue":{"issue":"32","published-online":{"date-parts":[[2022,6,21]]},"published-print":{"date-parts":[[2022,8,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac298","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,21]]},"published":{"date-parts":[[2022,6,21]]}}}